Fluorouracil (5FU) Speak to our specialist nurses on our free Support Line

Size: px
Start display at page:

Download "Fluorouracil (5FU) Speak to our specialist nurses on our free Support Line"

Transcription

1 1 Fluorouracil (5FU) This fact sheet is for anyone diagnosed with pancreatic cancer who would like to find out more about Fluorouracil (5-FU) chemotherapy to treat pancreatic cancer. It provides information about how 5FU is given and the side effects. Each hospital will do things slightly differently, and treatment will vary depending on your cancer, so speak to your doctor about your own situation. You can also speak to our specialist nurses on our Support Line about any questions you have about chemotherapy. You can call them free on , or 5FU is sometimes used after surgery to remove pancreatic cancer (known as adjuvant chemotherapy), instead of gemcitabine. It may also be used in combination with radiotherapy (chemoradiotherapy) for locally advanced cancers. 5FU is one of the drugs in FOLFIRINOX, a first-line treatment for advanced pancreatic cancer. It is also combined with leucovorin (folinic acid) and oxaliplatin in FOLFOX, a second-line treatment for advanced pancreatic cancer. How is 5FU given? You will have your chemotherapy as an outpatient in the chemotherapy unit, which means you ll go in for treatment, but won t need to stay overnight. 5-FU can be given as an injection into the vein or run through a special pump. You will be able to go home with this pump on. It can be given through a fine

2 2 plastic tube (cannula) inserted into a vein in your hand each time you have treatment. More often it will be given through a tube (central line) inserted into a vein in your arm or chest, which stays in place throughout your treatment. There may also be other options available. Read more about central lines and how they are inserted at Cancer Research UK. The dose of 5-FU, how often you have it, how long for, and whether you will have other drugs, varies. This will depend on whether you re having it with other treatments, in chemoradiotherapy or as second-line treatment. Speak to your oncologist about the details of your treatment. What are the side effects? 5FU can cause side effects, although everyone is affected in different ways. It s unusual to get all the possible side effects. There are ways to manage the side effects, and you may be given medication to help with some side effects. For example, you may be prescribed antisickness medication to deal with feeling sick (nausea). If you are prescribed medication you should take it exactly as you are told. Speak to your medical team if you get any side effects that you re worried about, or that aren t being properly controlled. You should have been given a phone number to contact them on. They can help you manage the side effects. Side effects can include the following. Sore mouth or mouth ulcers clean your teeth regularly with a soft toothbrush. Your doctor or nurse will be able to give you an antibacterial mouthwash that should help. Taste changes such as a metallic taste. You might find it helps to suck boiled sweets or use herbs in your food. Loose watery stools (diarrhoea). Make sure you drink plenty of fluids, and let your doctor or nurse know as they can give you medication to help. Eye problems gritty or watery eyes (as though you are crying). This can be helped with eye drops. Risk of infection from a low level of white blood cells called neutrophils (neutropenia). You may have headaches, aching muscles, a cough or sore throat or you may feel shivery and cold. This can be serious. You should contact the hospital straight away if your temperature goes above 37.5ºC or 38ºC (depending on the advice you ve been given by your chemotherapy team) or if you suddenly feel unwell, even if your temperature is normal. Bruising or bleeding, for example, nosebleeds or bleeding gums. This is caused by a low level of platelets.

3 3 Tiredness and breathlessness from anaemia, which is caused by a low level of red blood cells. You may need a blood transfusion to help you feel better. Fatigue (extreme tiredness). Fatigue can be difficult to manage. Take it easy, and make sure you rest when you need to. You might find it helps to take some gentle exercise, such as going for a short walk when you feel able. A good well balanced diet, and sorting out any other side effects or symptoms of the cancer can also help. Changes to how the heart works though this is usually temporary. If you have any pain or tightness in your chest, have an irregular heartbeat or feel breathless, let your doctor or nurse know straight away. Less common side effects include: Feeling or being sick (nausea or vomiting) your doctor will give you anti-sickness medication. Take it as soon as you feel sick. If it doesn t work, speak to your doctor or nurse to change it. Hair thinning. Changes to the nails your nails may darken or become flaky. Skin changes your skin may feel dry and itchy or be more sensitive to the sun. Use moisturiser, cover up, and use sun cream if you are outside. Let your doctor or nurse know about any skin changes. Soreness, redness and peeling on the palms of the hands and soles of the feet. Your doctor or nurse can prescribe cream or a vitamin to help with this. If the cream doesn t work, let your chemotherapy team know straight away. It usually improves after a break from treatment. You might also find it helps to keep your hands and feet cool. A blood clot forming in a blood vessel (thrombosis). If you have pain or swelling in your arms or legs or sudden shortness of breath, let your doctor or nurse know straight away. Read more about blood clots in a vein in our blood clot FAQ on our website at: pancreaticcancer.org.uk/dvtrisk. Ask your medical team for advice on managing these or any other side effects you experience. You can also call our specialist nurses free on our Support Line.

4 4 Read more about chemotherapy for pancreatic cancer and looking after yourself during chemotherapy on website at: pancreaticcancer.org.uk You can also read more information about 5FU on the Macmillan Cancer Support website. Pancreatic Cancer UK services c cancer. Our Support Line Our Support Line is a lifeline for thousands of patients, families and friends. Our specialist nurses understand the issues you might be facing. They are there for you, giving you personalised information and support that you need, when you need it. Call us free on (Monday to Friday from 10am-4pm), or us at Our information We have the most up-to-date information on everything you need to know about pancreatic cancer on our website. We can help you every step of the way, from explaining your diagnosis and treatment options, to managing symptoms, and questions to ask at your appointments. Go to pancreaticcancer.org.uk/informationandsupport Download or order our publications, for free, at pancreaticcancer.org.uk/publications Our online community Our online community is a supportive place where everyone affected by pancreatic cancer can be there for each other. Find us now at forum.pancreaticcancer.org.uk Support groups We help set up local support groups in communities all across the UK. These groups provide the opportunity for sharing personal experiences, understanding and support. Check to see if there s a group near you at pancreaticcancer.org.uk/supportgroups

5 5 Useful organisations CancerHelp UK Cancer nurses answer questions (Mon-Fri 9am-5pm) Information for patients from Cancer Research UK Macmillan Cancer Support Support Line: (Mon-Fri 9am-8pm) Provides practical, medical and financial support for anyone affected by cancer.

6 6 This fact sheet has been produced by the Support and Information Team at Pancreatic Cancer UK. It has been reviewed by health professionals and people affected by pancreatic cancer. References to the sources of information used to write this fact sheet and a list of health professionals who reviewed it are available on our website pancreaticcancer.org.uk Pancreatic Cancer UK makes every effort to make sure that our services provide up-to-date, unbiased and accurate information about pancreatic cancer. We hope that this information will add to the medical advice you have received and help you to take part in decisions related to your treatment and care. This information should not replace information and advice from your medical team please speak to your doctor, nurse or other members of your medical team about any questions or concerns. Give us your feedback We hope you have found this information helpful. We are always keen to improve our information, so let us know if you have any comments or suggestions. us at publications@pancreaticcancer.org.uk or write to the Information Manager at the address below. Pancreatic Cancer UK 2nd floor, Camelford House Albert Embankment London SE1 7TW enquiries@pancreaticcancer.org.uk pancreaticcancer.org.uk Pancreatic Cancer UK March 2015 Review date March 2017 Pancreatic Cancer UK is a charity registered in England and Wales ( ) and in Scotland (SC046392)

Capecitabine (Xeloda )

Capecitabine (Xeloda ) 1 Capecitabine (Xeloda ) This fact sheet is for anyone diagnosed with pancreatic cancer who would like to find out more about capecitabine chemotherapy to treat pancreatic cancer. It provides information

More information

Gemcitabine (Gemzar )

Gemcitabine (Gemzar ) 1 Gemcitabine (Gemzar ) This fact sheet is for anyone diagnosed with pancreatic cancer who would like to find out more about gemcitabine chemotherapy to treat pancreatic cancer. It provides information

More information

What is pancreatic cancer?

What is pancreatic cancer? 1 What is pancreatic cancer? This fact sheet provides an introduction to the function of the pancreas and pancreatic cancer. If you have any questions about pancreatic cancer, speak to our specialist nurses

More information

Irinotecan with fluorouracil (5FU) and folinic acid (FOLFIRI or IrMdG)

Irinotecan with fluorouracil (5FU) and folinic acid (FOLFIRI or IrMdG) 2010 fact sheet Macmillan and Cancerbackup have merged. Together we provide free, high quality information for all. Irinotecan with fluorouracil (5FU) and folinic acid (FOLFIRI or IrMdG) This information

More information

Cisplatin and Capecitabine

Cisplatin and Capecitabine Cisplatin and Capecitabine Cisplatin and Capecitabine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk

More information

MACE. Etoposide via an infusion (drip) over 1 hour, once a day for 5 days

MACE. Etoposide via an infusion (drip) over 1 hour, once a day for 5 days MACE MACE This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

Abemaciclib (Verzenios ) Abemaciclib (Verzenios )

Abemaciclib (Verzenios ) Abemaciclib (Verzenios ) Abemaciclib (Verzenios ) Abemaciclib (Verzenios ) Abemaciclib is a targeted (biological) therapy. This group of drugs block the growth and spread of cancer. They target and interfere with processes in

More information

Mitomycin C and Fluorouracil

Mitomycin C and Fluorouracil Mitomycin C and Fluorouracil Mitomycin C and Fluorouracil This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the

More information

Chemotherapy. In this fact sheet: Chemotherapy: English

Chemotherapy. In this fact sheet: Chemotherapy: English Chemotherapy: English Chemotherapy This information is about chemotherapy. Any words that are underlined are explained in the word list at the end. Many people with cancer will have chemotherapy as part

More information

Edinburgh Cancer Centre, Western General Hospital. Understanding Epirubicin, Oxaliplatin & 5-Fluorouracil Chemotherapy (EOF)

Edinburgh Cancer Centre, Western General Hospital. Understanding Epirubicin, Oxaliplatin & 5-Fluorouracil Chemotherapy (EOF) Introduction This booklet has been designed to help you and your family understand more about the chemotherapy that you are about to have as treatment for your cancer. If you need more information or have

More information

Low dose cytarabine (Low dose Ara C) Cancer Services Information for patients

Low dose cytarabine (Low dose Ara C) Cancer Services Information for patients Low dose cytarabine (Low dose Ara C) Cancer Services Information for patients i Introduction This leaflet is offered as a guide to you and your family; ideally it should be read with our general information

More information

Gemcitabine and carboplatin (Lung)

Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Fluorouracil and calcium folinate (Includes MdG (Modified degramont))

Fluorouracil and calcium folinate (Includes MdG (Modified degramont)) Fluorourcil and calcium folinate Fluorouracil and calcium folinate (Includes MdG (Modified degramont)) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary;

More information

Capecitabine (Xeloda) tablets

Capecitabine (Xeloda) tablets Capecitabine (Xeloda) tablets This is used with radiotherapy to treat colorectal cancer Information for patients Chemotherapy Name Hospital No Your consultant is Important Advice Always carry your chemotherapy

More information

Cisplatin and gemcitabine (GI)

Cisplatin and gemcitabine (GI) Cisplatin and gemcitabine (GI) Cisplatin and gemcitabine (GI) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce

More information

Pemetrexed (Alimta )

Pemetrexed (Alimta ) Pemetrexed (Alimta ) Pemetrexed (Alimta ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Epirubicin. Epirubicin

Epirubicin. Epirubicin Epirubicin Epirubicin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for

More information

High dose cytarabine (Lymphoma)

High dose cytarabine (Lymphoma) High dose cytarabine High dose cytarabine (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk

More information

Myocet. Myocet. Myocet is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Myocet. Myocet. Myocet is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour. Myocet Myocet This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others

More information

Gemcitabine and carboplatin (Breast)

Gemcitabine and carboplatin (Breast) Gemcitabine and carboplatin (Breast) Gemcitabine and carboplatin (Breast) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

Cisplatin and radiotherapy to the

Cisplatin and radiotherapy to the Cisplatin and radiotherapy to the head and neck Cisplatin and radiotherapy to the head and neck This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some

More information

Chemotherapy. Includes the following information

Chemotherapy. Includes the following information Macmillan and Cancerbackup have merged. Together we provide free, high quality information for all. Chemotherapy This fact sheet gives information about chemotherapy. Many people with cancer will have

More information

Pentostatin (Nipent )

Pentostatin (Nipent ) Pentostatin (Nipent ) Pentostatin (Nipent ) This leaflet is offered as a guide to you and your family. Your treatment will be fully explained by your doctor or nurse, who will be happy to answer any questions.

More information

Gemcitabine and Cisplatin (urology)

Gemcitabine and Cisplatin (urology) Gemcitabine and Cisplatin Gemcitabine and Cisplatin (urology) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce

More information

Pemetrexed (Alimta ) and cisplatin

Pemetrexed (Alimta ) and cisplatin Pemetrexed (Alimta ) and cisplatin Pemetrexed (Alimta ) and cisplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Cisplatin and 5-Fluorouracil (Urology)

Cisplatin and 5-Fluorouracil (Urology) Cisplatin and 5-Fluorouracil (Urology) Cisplatin and 5-Fluorouracil (Urology) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

Capecitabine chemotherapy and concurrent radiotherapy to the pancreas

Capecitabine chemotherapy and concurrent radiotherapy to the pancreas Capecitabine chemotherapy and concurrent radiotherapy to the pancreas Capecitabine chemotherapy and concurrent radiotherapy to the pancreas This leaflet is offered as a guide to you and your family. You

More information

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 (this is one cycle) for 2, 3 or 6 cycles.

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 (this is one cycle) for 2, 3 or 6 cycles. ABVD ABVD This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

Haematology. R - CEPP Chemotherapy

Haematology. R - CEPP Chemotherapy Haematology R - CEPP Chemotherapy This information is about R-CEPP chemotherapy, which is a treatment for Lymphoma. Lymphoma is a cancer of the lymphatic system a network of glands in the body that helps

More information

tumours tumours Temozolamide and capecitabine for pancreatic neuroendocrine tumours

tumours tumours Temozolamide and capecitabine for pancreatic neuroendocrine tumours Temozolamide and capecitabine for pancreatic neuroendocrine tumours tumours tumours Temozolomide and capecitabine for pancreatic neuroendocrine tumours This leaflet is offered as a guide to you and your

More information

Methotrexate. You will have a routine blood test before the start of each cycle of treatment.

Methotrexate. You will have a routine blood test before the start of each cycle of treatment. Methotrexate Methotrexate This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back,

More information

Docetaxel (Taxotere) This booklet explains what docetaxel is, how it works, when it may be prescribed and the side effects you may experience.

Docetaxel (Taxotere) This booklet explains what docetaxel is, how it works, when it may be prescribed and the side effects you may experience. Docetaxel (Taxotere) This booklet explains what docetaxel is, how it works, when it may be prescribed and the side effects you may experience. 2 Call our Helpline on 0808 800 6000 What is docetaxel? Docetaxel

More information

Paclitaxel (Taxol) and carboplatin

Paclitaxel (Taxol) and carboplatin Paclitaxel (Taxol) and carboplatin Paclitaxel (Taxol) and carboplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Intravenous anti-cancer treatment

Intravenous anti-cancer treatment Intravenous anti-cancer treatment Information for patients Chemotherapy Name Hospital No Your consultant is Anti-cancer treatment is the term used to describe medicines used to treat cancer including chemotherapy.

More information

Haematology. C = Cyclophosphamide (pronounced sigh clo fos fa mide)

Haematology. C = Cyclophosphamide (pronounced sigh clo fos fa mide) Haematology CEPP Chemotherapy This information is about CEPP chemotherapy, which is a treatment for Lymphoma. Lymphoma is a cancer of the lymphatic system - a network of glands in the body that helps to

More information

Docetaxel (Taxotere) with GCSF

Docetaxel (Taxotere) with GCSF Docetaxel (Taxotere) with GCSF Docetaxel (Taxotere) with GCSF for hormone This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

Vinblastine (Lymphoma)

Vinblastine (Lymphoma) Vinblastine (Lymphoma) Vinblastine (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

Oral cyclophosphamide in ovarian cancer

Oral cyclophosphamide in ovarian cancer Oral cyclophosphamide in ovarian cancer Oral cyclophosphamide in ovarian cancer This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

Paclitaxel (Taxol) Paclitaxel is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Paclitaxel (Taxol) Paclitaxel is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour. Paclitaxel (Taxol) Paclitaxel (Taxol) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Mitomycin C given by injection into a vein. Cisplatin and hydration (fluids) via a drip over 6 or 18 hours.

Mitomycin C given by injection into a vein. Cisplatin and hydration (fluids) via a drip over 6 or 18 hours. Cisplatin & Mitomycin C Cisplatin & Mitomycin C This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

Department of Clinical Haematology. Chemotherapy. Information for patients. Page 1 of 12

Department of Clinical Haematology. Chemotherapy. Information for patients. Page 1 of 12 Department of Clinical Haematology Chemotherapy Information for patients Page 1 of 12 You may find this booklet helpful if you or someone close to you is going to have chemotherapy. It explains: what chemotherapy

More information

Etoposide Cisplatin / Etoposide, Methotrexate, Actinomycin

Etoposide Cisplatin / Etoposide, Methotrexate, Actinomycin Etoposide Cisplatin / Etoposide, Methotrexate, Actinomycin Information for patients Chemotherapy Important Advice Always carry your chemotherapy alert card. It is important that you know what to do if

More information

ALL Consolidation (cycles 1-4)

ALL Consolidation (cycles 1-4) ALL Consolidation (Cycles 1-4) ALL Consolidation (cycles 1-4) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce

More information

Your treatment. 240 BEP 3 Days Page 1 of 6

Your treatment. 240 BEP 3 Days Page 1 of 6 BEP - 3 Days BEP - 3 Days This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back,

More information

Vinorelbine (Oral) Oral Vinorelbine

Vinorelbine (Oral) Oral Vinorelbine Oral Vinorelbine Vinorelbine (Oral) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming

More information

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets ChIVPP ChIVPP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others

More information

For the Patient: LUAVPG (Carboplatin Option)

For the Patient: LUAVPG (Carboplatin Option) For the Patient: LUAVPG (Carboplatin Option) Other Names: Treatment of Advanced n-small Cell Lung Cancer with Carboplatin and Gemcitabine LU = LUng AV = AdVanced PG = CarboPlatin, Gemcitabine ABOUT THIS

More information

Oral Etoposide (Lymphoma)

Oral Etoposide (Lymphoma) Oral Etoposide (Lymphoma) Oral Etoposide (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk

More information

Doxorubicin & Ifosfamide

Doxorubicin & Ifosfamide Doxorubicin & Ifosfamide Doxorubicin & Ifosfamide This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of

More information

Gemcitabine and carboplatin (Lung)

Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Treatment FLAG. An information guide

Treatment FLAG. An information guide TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Treatment FLAG An information guide Treatment FLAG This leaflet is offered as a guide to you and your family. The possible benefits of treatment

More information

VDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks.

VDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks. VDC IE VDC IE This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others

More information

Pertuzumab (Perjeta)

Pertuzumab (Perjeta) Pertuzumab (Perjeta) This booklet explains what pertuzumab is, when it s given and its possible side effects. Pertuzumab is the generic (non-branded) name of the drug, and is how it s referred to in this

More information

VIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours

VIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours VIDE VIDE This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers Medication Information Sheet (pack li TAX ell) This document provides general information about your medication. It does not replace the advice of your health care professional. Always discuss your therapy

More information

Afatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally.

Afatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally. Afatinib (Giotrif) Afatinib (Giotrif ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth. For the Patient: Other names: Sorafenib NEXAVAR Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth. A blood test may be taken before each

More information

GCVP. Cyclophosphamide by injection Vincristine by short infusion. Gemcitabine by infusion over 30 minutes

GCVP. Cyclophosphamide by injection Vincristine by short infusion. Gemcitabine by infusion over 30 minutes GCVP GCVP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

Treatment FLAG-IDA. An information guide

Treatment FLAG-IDA. An information guide TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Treatment FLAG-IDA An information guide Treatment FLAG-IDA This leaflet is offered as a guide to you and your family. The possible benefits

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Oxaliplatin- Fluorouracil (FOLFOX) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)

More information

Myeloma Haematology and Transplant Unit

Myeloma Haematology and Transplant Unit BCD Myeloma Haematology and Transplant Unit BCD This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC)

Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC) Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC) Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC) This leaflet is offered as a guide to you and your family. The possible benefits of treatment

More information

GDP GDP Gemcitabine, Dexamethasone, CisPlatin Your treatment Day 1 Days 1 to 4 Day 8 dexamethasone

GDP GDP Gemcitabine, Dexamethasone, CisPlatin Your treatment Day 1 Days 1 to 4 Day 8 dexamethasone GDP GDP Gemcitabine, Dexamethasone, CisPlatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Docetaxel-Oxaliplatin- Fluorouracil (FLOT) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other

More information

For the Patient: CAP. Capecitabine. Uses:

For the Patient: CAP. Capecitabine. Uses: For the Patient: CAP Other names: BRAVCAP CAP Capecitabine Uses: BRAVCAP is an oral chemotherapy drug treatment plan, given as therapy for metastatic breast cancer, in the hope of destroying breast cancer

More information

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 of a 28 day cycle. You will have 2, 3 or 6 cycles.

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 of a 28 day cycle. You will have 2, 3 or 6 cycles. ABVD ABVD This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

Myeloma Haematology and Transplant Unit CTD1

Myeloma Haematology and Transplant Unit CTD1 CTD1 Myeloma Haematology and Transplant Unit CTD1 This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of

More information

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine. Bendamustine Bendamustine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back,

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: FEC-P PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP: MALE

More information

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: Trastuzumab emtansine Other names: KADCYLA For the Patient: Trastuzumab emtansine Other names: KADCYLA Trastuzumab emtansine (tras tooz' ue mab em tan' seen) is a drug that is used to treat some types of cancer. Trastuzumab emtansine is a clear

More information

Weekly standard dose. Paclitaxel (Taxol) and carboplatin

Weekly standard dose. Paclitaxel (Taxol) and carboplatin paclitaxel (taxol) and carboplatin Paclitaxel (Taxol) and carboplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Carboplatin and Capecitabine

Carboplatin and Capecitabine Carboplatin and Capecitabine Carboplatin and Capecitabine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the

More information

Patient guide to Capecitabine chemotherapy with radiotherapy for rectal cancer

Patient guide to Capecitabine chemotherapy with radiotherapy for rectal cancer Patient Name: Patient guide to chemotherapy with radiotherapy for rectal cancer Chemotherapy This guide should only be given to patients who have been prescribed capecitabine chemotherapy in conjunction

More information

Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer)

Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer) Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer) The possible benefits of treatment vary; for some people chemotherapy may reduce the

More information

Myeloma Haematology and Transplant Unit MPT

Myeloma Haematology and Transplant Unit MPT MPT Myeloma Haematology and Transplant Unit MPT This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

How is primary breast cancer treated? This booklet is for anyone who has primary breast cancer and wants to know more about how it is treated.

How is primary breast cancer treated? This booklet is for anyone who has primary breast cancer and wants to know more about how it is treated. How is primary breast cancer treated? This booklet is for anyone who has primary breast cancer and wants to know more about how it is treated. How is primary breast cancer treated? Part 1 the treatment

More information

For the Patient: Sunitinib Other names: SUTENT

For the Patient: Sunitinib Other names: SUTENT For the Patient: Sunitinib Other names: SUTENT Sunitinib (soo-ni-ti-nib) is a drug that is used to treat different types of cancer. It is a capsule that you take by mouth. A blood test and blood pressure

More information

The treatment is given every 3 weeks for 6 to 8 cycles.

The treatment is given every 3 weeks for 6 to 8 cycles. R-CVP R-CVP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it

More information

Hospital No. Weston Park Hospital contact number

Hospital No. Weston Park Hospital contact number Pemetrexed Information for patients Chemotherapy Name Hospital No Your consultant is Important Advice Always carry your chemotherapy alert card. It is important that you know what to do if you feel ill

More information

Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients

Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients This booklet has been written to give you more information about bevacizumab (commonly known as Avastin). This

More information

For the Patient: Lenvatinib Other names: LENVIMA

For the Patient: Lenvatinib Other names: LENVIMA For the Patient: Lenvatinib Other names: LENVIMA Lenvatinib (len va' ti nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth. Tell your doctor if you have ever

More information

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine GI = GastroIntesntinal P = Pancreatic AJ = Adjuvant GEM = Gemcitabine ABOUT THIS MEDIATION What is this

More information

Traztuzumab (Herceptin)

Traztuzumab (Herceptin) Traztuzumab (Herceptin) Information for patients Chemotherapy Name Hospital No Your consultant is Important Advice Always carry your chemotherapy alert card. It is important that you know what to do if

More information

ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.

ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer. For the Patient: HNNAVGEM Treatment of Recurrent or Metastatic Nasopharyngeal Cancer with Gemcitabine HN = Head and Neck N = Nasopharyngeal AV = Advanced GEM = Gemcitabine ABOUT THIS MEDICATION What is

More information

Large granular lymphocytic leukaemia (LGLL)

Large granular lymphocytic leukaemia (LGLL) Bloodwise Patient Information Large granular lymphocytic leukaemia (LGLL) For anyone affected by blood cancer Large granular lymphocytic leukaemia (LGLL) This fact sheet will help you to understand LGLL,

More information

Capecitabine (breast)

Capecitabine (breast) Capecitabine (breast) Capecitabine (breast) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Cisplatin- Capecitabine- Trastuzumab PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)

More information

Mitomycin C by bolus [short] injection followed by capecitabine tablets which can be started the next day.

Mitomycin C by bolus [short] injection followed by capecitabine tablets which can be started the next day. Mitomycin C and Capecitabine Mitomycin C and Capecitabine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the

More information

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: Ponatinib Other names: ICLUSIG For the Patient: Other names: ICLUSIG (poe na' ti nib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. The tablet contains lactose. Tell your doctor if you

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Docetaxel-EC PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

Surgery. In this fact sheet. Surgery: English

Surgery. In this fact sheet. Surgery: English Surgery: English Surgery This information is about surgery (having an operation). Any words that are underlined are explained in the glossary at the end. Many people with cancer will have surgery as part

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Sunitinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre

High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre High dose melphalan conditioning for autologous transplant (inpatient) High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre This leaflet is offered as a guide

More information

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct. For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct. GI = GastroIntestinal P = Pancreas GEM = Gemcitabine ABOUT THIS MEDIATION What is this drug used for? Gemcitabine

More information

Bowel cancer. In this fact sheet: Page 1 of 13 Macmillan fact sheet 2017: Bowel cancer. Bowel Cancer: English

Bowel cancer. In this fact sheet: Page 1 of 13 Macmillan fact sheet 2017: Bowel cancer. Bowel Cancer: English Bowel Cancer: English Bowel cancer This information is about bowel cancer and treatments for bowel cancer. Any words that are underlined are explained in the word list at the end. If you have any questions,

More information

For the Patient: Everolimus tablets Other names: AFINITOR

For the Patient: Everolimus tablets Other names: AFINITOR For the Patient: Everolimus tablets Other names: AFINITOR Everolimus (e'' ver oh' li mus) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. Tell your doctor if

More information

Pazopanib (Votrient ) oral for renal tumours

Pazopanib (Votrient ) oral for renal tumours Pazopanib (Votrient )oral for renal tumours Pazopanib (Votrient ) oral for renal tumours This leaflet is offered as a guide to you and your family. Pazopanib (Votrient ) is a type of medicine called a

More information

455 Pemetrexed (Alimta ) cisplatin Page 1 of 6

455 Pemetrexed (Alimta ) cisplatin Page 1 of 6 Pemetrexed (Alimta ) and cisplatin Pemetrexed (Alimta ) and cisplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information